How many clinical trials are tracked of idarucizumab?

6 trials are tracked, 2 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

idarucizumab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of idarucizumab

6 trials tracked of idarucizumab: 4 in phase 3 or 4 and 2 with published results. The most-cited published study has 1451 citations.

6Trials tracked

4Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 3 4 Phase 1 2

Phase 3 Reversal of Dabigatran Anticoagulant Effect With Idarucizumab Completed · 1,451 cited
Phase 3 Reversal Dabigatran Anticoagulant Effect With Idarucizumab Completed · 15 cited
Phase 3 CU Programme of Idarucizumab for Japanese Patients Completed
Phase 3 This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding Completed
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects Completed
Phase 1 Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.